The decline in profitability of domestic pharmacists severely hits the Russian patients.
Drug manufacturers in the Russian Federation refuse to make the preparations from the list vital and essential.
In particular, a number of positions from the list of medicines manufactured struck out more in 2015 Pharmaceutical factory of St. Petersburg.
Prices of imported raw materials in view of the sharp fall of the ruble rose, while prices for the medicines themselves, which in this case are limited to government, producers can not raise. In the end, the profitability of production is falling off a cliff, and pharmacists becomes easier to abandon the manufacture of drugs than work at a loss. Factory revenue from the sale of drugs almost halved.
This situation, unfortunately, is becoming ubiquitous. In 2015 about 80 kinds of preparations from the list Vital and the major were discontinued on 26 pharmaceutical companies. The net loss from production of these medicines on the number of factories rose to 40%. Usually, we are talking about medications that are cheaper 50 rubles.
In the list of 646 drugs today, more than two thirds of them are produced in Russia (or more correctly, was made?). According to official information, by the end of 2015, the year they rose by an average of almost 9% (and most of all raised the price of the ones that were the least expensive of them — 16%). An independent expert Agency, however, called much lower level of price growth. On the list of drugs now account for about 50% of the market in packages and about 6.5% — in the money.
Russian President Vladimir Putin during a “straight line” on April 14, 2016 gave the Executive authorities has until June to identify ways to support pharmacists, which produce cheap drugs from the essential drugs list.
The government’s plan for 2016 producers of inexpensive essential drugs are provided support in the form of subsidies. Here are the experts say that “help” the authorities may be delayed. The fact that a significant proportion of companies may stop producing unprofitable drugs before Jun. Subsidies then they may receive, so only register the drugs again they will be able only in a year. Formed also on the market, the void will eventually hit people, and, primarily, to the poor.
In General, one gets the impression that some authorities are doing everything possible to Russia is no longer repeated their records of life expectancy of the population.
